Barcelona, octubre de 2012.- El grupo de investigación en enfermedades neurovasculares del Vall d’Hebrón Institut de Recerca (VHIR) es el único participante español en el mayor estudio genético sobre ictus realizado a nivel mundial. El trabajo ha estudiado el código genético de más de 72.000 personas entre enfermos y controles y concluye que la clasificación de los ictus según su causa va más allá de la propia enfermedad y se traduce también en claras diferencias genéticas entre los tres subtipos de ictus isquémicos conocidos. Estos hallazgos tendrán, a la larga, un gran impacto clínico, pues cambian la forma de ver el ictus pero, sobre todo, son la puerta de acceso a la búsqueda de dianas terapéuticas específicas para cada uno de estos subtipos. El estudio se ha publicado en la revista The Lancet Neurology y se trata de un estudio multicéntrico y sin precedentes.
Granada, octubre de 2012.- “Andalucía sigue a la cola en la atención al Ictus”. Así lo ha manifestado el doctor Santiago Cousido, presidente de la Sociedad Andaluza de Neurología (SAN) al concluir un coloquio sobre esta enfermedad en el marco de la XXXV Reunión Anual, celebrada en el Hotel Abades Nevada Palace.
Brett Kissela, University of Cincinnati College of Medicine in Ohio, USA, and colleagues have found that stroke incidence may be affecting younger adults. The study is published in the 10 October online issue of Neurology.
On 16 October, Stryker announced a definitive agreement to acquire Surpass Medical. This privately-held company develops next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system.
Neuralstem has reported positive clinical outcomes for Neuralstem’s NSI-566 spinal cord-derived neural stem cell line in a rat model of ischaemic stroke. Data has shown significant improvement in both motor and neurological tests in the stem cell-treated rats.
October 16, 2012—Stryker Corporation (Kalamazoo, MI) announced a definitive agreement to acquire Surpass Medical, Ltd. (Tel Aviv, Israel), which is developing and commercializing next-generation flow diversion stent technology for the treatment of brain aneurysms. Surpass was founded in 2005 in Tel Aviv, with manufacturing and research and development facilities in Miramar, Florida.
The Kalamazoo-based medical device maker announced Oct. 16 it is purchasing Surpass Medical, Ltd., for $135 million. Stryker will pay $100 million in cash for the privately held company, with up to $35 million in additional milestone payments.
A small non-randomised study, led by Ronen R Leker, Hebrew University Hadassah Medical Centre, Jerusalem, Israel, published in Stroke, indicates that in patients with proximal middle cerebral artery occlusion (pMCOA), stent-based thrombectomy may be associated with more favourable outcomes than intravenous tissue plasminogen activator (tPA).
Scientists in Canada have found that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair brain aneurysms, compared to placebo, and appears to be safe to use. The study has been published online in The Lancet Neurology.
If you eat plenty of tomatoes your risk of having a stroke will probably be lower, scientists from the University of Eastern Finland in Kuopio revealed in the October 9th issue of Neurology. The authors added that lycopene, an antioxidant in tomatoes, appears to have the stroke-prevention benefits.
St Jude Medical has announced the publication of results from the first large scale study of peripheral nerve stimulation (PNS) of the occipital nerves in patients suffering from chronic migraine. The study results, published online by Cephalalgia the journal of the International Headache Society, show a significant reduction in pain, headache days and migraine-related disability.
A new Mayo Clinic study confirms the use of smartphones medical images to evaluate patients in remote locations through telemedicine. The study, the first to test the effectiveness of smartphone teleradiology applications in a real-world telestroke network, was recently published in Stroke, a journal of the American Heart Association.
Over the past two decades, computer simulation has become an increasingly important tool in scientific research and engineering design. In the aerospace industry for example, simulation has become the standard tool for predicting performance of a newly designed part, well before the part is physically built. In clinical medicine, computer simulation is emerging as a viable option for surgical training and planning. For example, neurosurgical simulators now allow a user to navigate a catheter through challenging patient-specific anatomy and to deploy different endovascular devices including coils, stents, and flow diverters. These new simulators represent an important breakthrough in advancing surgical training toward life-like realism, and medical device companies have also begun to use them for demonstrating the deployment of emerging endovascular devices.
MRI Interventions and Brainlab AG have announced the first two cases performed in Europe with the ClearPoint Neuro Intervention System.
Home delivery of stroke rehabilitation improves care, eliminates waiting lists for treatment and saves hundreds of thousands of dollars annually in hospital costs, according to a quality improvement project presented at the Canadian Stroke Congress.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos